As of 2025-10-21, the EV/EBITDA ratio of Harpoon Therapeutics Inc (HARP) is -18.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HARP's latest enterprise value is 483.51 mil USD. HARP's TTM EBITDA according to its financial statements is -26.68 mil USD. Dividing these 2 quantities gives us the above HARP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 13.4x | 11.2x |
| Forward P/E multiples | 12.1x - 20.4x | 16.2x |
| Fair Price | (14.67) - (16.29) | (16.70) |
| Upside | -163.8% - -170.8% | -172.6% |
| Date | EV/EBITDA |